KCM
BLFS icon

Kennedy Capital Management’s BioLife Solutions BLFS Stock Holding History

Kennedy Capital Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-82,111
Closed -$1.79M – 667
2023
Q1 		$1.79M Sell
82,111
-122,808
-60% -$2.76M 0.05% 422
2022
Q4 		$3.73M Buy
204,919
+58,457
+40% +$1.21M 0.11% 325
2022
Q3 		$3.33M Buy
+146,462
New +$3.13M 0.1% 340

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Kennedy Capital Management's BLFS Position: Q2 2023 in Review

Kennedy Capital Management sold out of BioLife Solutions (BLFS) in Q2 2023, closing a stake of 82,111 shares — an estimated $1.79M sold.

Kennedy Capital Management first reported a position in BLFS in Q3 2022 and held it in 3 quarters. The position peaked at $3.73M in Q4 2022. 156 funds tracked by Wall St. Rank hold BLFS as of Q2 2023.

  • Kennedy Capital Management reported no remaining BioLife Solutions position as of Q2 2023 after selling out during the quarter.
  • Kennedy Capital Management sold 82,111 BioLife Solutions shares in Q2 2023, an estimated $1.79M.
  • Kennedy Capital Management first reported a position in BioLife Solutions in Q3 2022 and held it in 3 quarters.
  • Kennedy Capital Management's BioLife Solutions position peaked at $3.73M in Q4 2022.
  • 156 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2023.

Based on Kennedy Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.